Cargando…
An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing
Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968515/ https://www.ncbi.nlm.nih.gov/pubmed/31988805 http://dx.doi.org/10.7717/peerj.8370 |
_version_ | 1783489149381115904 |
---|---|
author | Shi, Xiaodong Shao, Tihong Huo, Feifei Zheng, Chenqing Li, Wanyu Jiang, Zhenyu |
author_facet | Shi, Xiaodong Shao, Tihong Huo, Feifei Zheng, Chenqing Li, Wanyu Jiang, Zhenyu |
author_sort | Shi, Xiaodong |
collection | PubMed |
description | Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc patients and four healthy controls were characterized by high-throughput sequencing, and bioinformatics analysis were studied. The average CDR3 length in the SSc group was significantly shorter. The SSc patient displayed more diverse BCR. Moreover, SSc patients with mild skin sclerosis, anti-Scl70, interstitial lung disease or female sex were more diversified. B cells from the SSc patients showed a differential V and J gene usage. SSc patients had distinct BCR repertoires.These findings reflected the differences of BCR repertoires between SSc patients and controls. The higher-usage genes for the BCR sequence might be potential biomarkers of B cell-targeted therapies or diagnosis for SSc. |
format | Online Article Text |
id | pubmed-6968515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69685152020-01-27 An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing Shi, Xiaodong Shao, Tihong Huo, Feifei Zheng, Chenqing Li, Wanyu Jiang, Zhenyu PeerJ Immunology Systemic sclerosis is a chronic multisystem autoimmune disease that is associated with polyclonal B cell hyperreactivity. The CDR3 of BCRs is the major site of antigen recognition. Therefore, we analyzed the BCR repertoire of patients with SSc. The BCR repertoires in 12 subjects including eight SSc patients and four healthy controls were characterized by high-throughput sequencing, and bioinformatics analysis were studied. The average CDR3 length in the SSc group was significantly shorter. The SSc patient displayed more diverse BCR. Moreover, SSc patients with mild skin sclerosis, anti-Scl70, interstitial lung disease or female sex were more diversified. B cells from the SSc patients showed a differential V and J gene usage. SSc patients had distinct BCR repertoires.These findings reflected the differences of BCR repertoires between SSc patients and controls. The higher-usage genes for the BCR sequence might be potential biomarkers of B cell-targeted therapies or diagnosis for SSc. PeerJ Inc. 2020-01-14 /pmc/articles/PMC6968515/ /pubmed/31988805 http://dx.doi.org/10.7717/peerj.8370 Text en ©2020 Shi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Immunology Shi, Xiaodong Shao, Tihong Huo, Feifei Zheng, Chenqing Li, Wanyu Jiang, Zhenyu An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title | An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title_full | An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title_fullStr | An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title_full_unstemmed | An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title_short | An analysis of abnormalities in the B cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
title_sort | analysis of abnormalities in the b cell receptor repertoire in patients with systemic sclerosis using high-throughput sequencing |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968515/ https://www.ncbi.nlm.nih.gov/pubmed/31988805 http://dx.doi.org/10.7717/peerj.8370 |
work_keys_str_mv | AT shixiaodong ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT shaotihong ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT huofeifei ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT zhengchenqing ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT liwanyu ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT jiangzhenyu ananalysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT shixiaodong analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT shaotihong analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT huofeifei analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT zhengchenqing analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT liwanyu analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing AT jiangzhenyu analysisofabnormalitiesinthebcellreceptorrepertoireinpatientswithsystemicsclerosisusinghighthroughputsequencing |